skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Gale Academic OneFile (Gale Reference Complete) remover assunto: Liver Neoplasms - Drug Therapy remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis

Hiraoka, Atsushi ; Kumada, Takashi ; Atsukawa, Masanori ; Hirooka, Masashi ; Tsuji, Kunihiko ; Ishikawa, Toru ; Takaguchi, Koichi ; Kariyama, Kazuya ; Itobayashi, Ei ; Tajiri, Kazuto ; Shimada, Noritomo ; Shibata, Hiroshi ; Ochi, Hironori ; Tada, Toshifumi ; Toyoda, Hidenori ; Nouso, Kazuhiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Hayama, Korenobu ; Imai, Michitaka ; Joko, Kouji ; Koizumi, Yohei ; Hiasa, Yoichi ; Michitaka, Kojiro ; Kudo, Masatoshi

Cancer medicine (Malden, MA), 2019-07, Vol.8 (8), p.3719-3728 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
2
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience

Hiraoka, Atsushi ; Kumada, Takashi ; Tada, Toshifumi ; Hirooka, Masashi ; Kariyama, Kazuya ; Tani, Joji ; Atsukawa, Masanori ; Takaguchi, Koichi ; Itobayashi, Ei ; Fukunishi, Shinya ; Tsuji, Kunihiko ; Ishikawa, Toru ; Tajiri, Kazuto ; Ochi, Hironori ; Yasuda, Satoshi ; Toyoda, Hidenori ; Ogawa, Chikara ; Nishimura, Takashi ; Hatanaka, Takeshi ; Ohama, Hideko ; Nouso, Kazuhiro ; Morishita, Asahiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Okubo, Tomomi ; Arai, Taeang ; Imai, Michitaka ; Koizumi, Yohei ; Nakamura, Shinichiro ; Joko, Kouji ; Iijima, Hiroko ; Hiasa, Yoichi ; Kudo, Masatoshi

Cancer Reports, 2022-02, Vol.5 (2), p.e1464-n/a [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
3
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib

Hiraoka, Atsushi ; Kumada, Takashi ; Tada, Toshifumi ; Hirooka, Masashi ; Kariyama, Kazuya ; Tani, Joji ; Atsukawa, Masanori ; Takaguchi, Koichi ; Itobayashi, Ei ; Fukunishi, Shinya ; Tsuji, Kunihiko ; Ishikawa, Toru ; Tajiri, Kazuto ; Ochi, Hironori ; Yasuda, Satoshi ; Toyoda, Hidenori ; Ogawa, Chikara ; Nishimura, Takashi ; Hatanaka, Takeshi ; Kakizaki, Satoru ; Shimada, Noritomo ; Kawata, Kazuhito ; Naganuma, Atsushi ; Kosaka, Hisashi ; Shibata, Hiroshi ; Aoki, Tomoko ; Tanaka, Takaaki ; Ohama, Hideko ; Nouso, Kazuhiro ; Morishita, Asahiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Okubo, Tomomi ; Arai, Taeang ; Imai, Michitaka ; Koizumi, Yohei ; Nakamura, Shinichiro ; Joko, Kouji ; Iijima, Hiroko ; Kaibori, Masaki ; Hiasa, Yoichi ; Kudo, Masatoshi

Cancer medicine (Malden, MA), 2023-01, Vol.12 (1), p.325-334 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
4
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

Hiraoka, Atsushi ; Kumada, Takashi ; Tada, Toshifumi ; Hirooka, Masashi ; Kariyama, Kazuya ; Tani, Joji ; Atsukawa, Masanori ; Takaguchi, Koichi ; Itobayashi, Ei ; Fukunishi, Shinya ; Tsuji, Kunihiko ; Ishikawa, Toru ; Tajiri, Kazuto ; Ochi, Hironori ; Yasuda, Satoshi ; Toyoda, Hidenori ; Ogawa, Chikara ; Nishimura, Takashi ; Hatanaka, Takeshi ; Kakizaki, Satoru ; Shimada, Noritomo ; Kawata, Kazuhito ; Naganuma, Atsushi ; Kosaka, Hisashi ; Ohama, Hideko ; Tada, Fujimasa ; Nouso, Kazuhiro ; Morishita, Asahiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Okubo, Tomomi ; Arai, Taeang ; Imai, Michitaka ; Koizumi, Yohei ; Nakamura, Shinichiro ; Iijima, Hiroko ; Kaibori, Masaki ; Hiasa, Yoichi ; Kudo, Masatoshi

Oncology, 2022-12, Vol.100 (12), p.645-654 [Periódico revisado por pares]

Basel, Switzerland: S. Karger AG

Texto completo disponível

Citações Citado por
5
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach

Hatanaka, Takeshi ; Kakizaki, Satoru ; Hiraoka, Atsushi ; Tada, Toshifumi ; Hirooka, Masashi ; Kariyama, Kazuya ; Tani, Joji ; Atsukawa, Masanori ; Takaguchi, Koichi ; Itobayashi, Ei ; Fukunishi, Shinya ; Tsuji, Kunihiko ; Ishikawa, Toru ; Tajiri, Kazuto ; Ochi, Hironori ; Yasuda, Satoshi ; Toyoda, Hidenori ; Ogawa, Chikara ; Yokohama, Keisuke ; Nishikawa, Hiroki ; Nishimura, Takashi ; Shimada, Noritomo ; Kawata, Kazuhito ; Kosaka, Hisashi ; Naganuma, Atsushi ; Yata, Yutaka ; Ohama, Hideko ; Kuroda, Hidekatsu ; Tanaka, Kazunari ; Tanaka, Takaaki ; Tada, Fujimasa ; Nouso, Kazuhiro ; Morishita, Asahiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Okubo, Tomomi ; Arai, Taeang ; Imai, Michitaka ; Koizumi, Yohei ; Nakamura, Shinichiro ; Kaibori, Masaki ; Iijima, Hiroko ; Hiasa, Yoichi ; Kudo, Masatoshi ; Kumada, Takashi

Cancer medicine (Malden, MA), 2023-12, Vol.12 (24), p.21680-21693 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
6
Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study
Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study

Ogawa, Chikara ; Morita, Masahiro ; Omura, Akina ; Noda, Teruyo ; Kubo, Atsushi ; Matsunaka, Toshihiro ; Tamaki, Hiroyuki ; Shibatoge, Mitsushige ; Tsutsui, Akemi ; Senoh, Tomonori ; Nagano, Takuya ; Takaguchi, Kouichi ; Tani, Joji ; Morishita, Asahiro ; Yoneyama, Hirohito ; Masaki, Tsutomu ; Moriya, Akio ; Ando, Masaharu ; Deguchi, Akihiro ; Kokudo, Yasutaka ; Minami, Yasunori ; Ueshima, Kazuomi ; Sakurai, Toshiharu ; Nishida, Naoshi ; Kudo, Masatoshi

Oncology, 2017-01, Vol.93 (1), p.113-119 [Periódico revisado por pares]

Basel, Switzerland

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.